The only thing im sure about with this company is that its drug has great potential

This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.

if this is truly a 4B, 5B or more mkt cap drug it’ll ultimately end up with a SP in the hundreds of dollars (assuming RS goes through) and everyone will be happy in the long run.

Despite everything, the fact remains that absolutely nobody has come up with anything substantially bad to report about this amazing drug.

MIRACLE DRUG CHEAP SHARES HERE $HEPA! !

For any investor, being able to buy the company below cash value while getting the wonder drug, Rencofilstat, for free is a VERY attractive investment proposition.

That drug has been proven to be safe to be used in tandem with any other known drugs.

$HEPA this drug is game changer in hepatology!

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.

Health departments all over the US handing out free boxes of drug and needle kits at no cost.

$RAD just grabbed some shares..either up or 0…but I feel like there is actual value here..it’s a Drug Store..

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.

“Unlike single- or multi-dose vials that may require drug product overfill by as much as 30% to ensure adequate withdrawal, a prefilled syringe can virtually eliminate the need for excess overfill, thus conserving expensive drug products.

Sharps Technology’s solutions will support the future demand of specialty polymer-based syringe drug filling solutions, and its products should address the demand in the growing market for them.